Buscar resultados de ensayos clínicos
Glomerulonephritis, Membranoproliferative - 10 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis Condición: Glomerulonephritis, Membranoproliferative Fecha: 2006-01-10 Intervenciones: Drug: Rituximab The Rituximab dose is 1000 mg (1 gm) given as an IV infusion every two weeks for 2 doses |
Active, not recruiting |
Nombre del estudio: Eculizumab in Primary MPGN Condición: Membranoproliferative Glomerulonephritis Fecha: 2014-03-17 Intervenciones: Drug: Eculizumab Other Name: Soliris |
Not yet recruiting |
Nombre del estudio: Daratumumab in Treatment of PGNIMD and C3 GN Condición: Membranoproliferative Glomerulonephritis Fecha: 2017-03-20 Intervenciones: Drug: Daratumumab Open-label Other Name: Darzalex |
Completed |
Nombre del estudio: BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis Condición:
Fecha: 1999-11-03 Intervenciones: Drug: BG9588 |
Not yet recruiting |
Nombre del estudio: A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN Condición:
|
Terminated |
Nombre del estudio: Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease Condición:
|
Withdrawn |
Nombre del estudio: TP10 Use in Patients With C3 Glomerulopathy (C3G) Condición: Dense Deposit Disease Fecha: 2014-11-05 Intervenciones: Drug: TP10 All patients will be enrolled through the University of Iowa. This study will follow a patien |
Withdrawn |
Nombre del estudio: Sulodexide Treatment in Patients With Dense Deposit Disease Condición: Dense Deposit Disease Fecha: 2007-12-20 Intervenciones: Drug: Sulodexide 200 mg per day in an oral gelcap form |
Recruiting |
Nombre del estudio: Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 Condición:
|